The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Viscosupplementation for Joint Market Research Report 2025
Synopsis
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global Injectable Viscosupplementation for Joint market was valued at US$ 1822 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation for Joint, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation for Joint.
Report Scope
The Injectable Viscosupplementation for Joint market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Viscosupplementation for Joint market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Viscosupplementation for Joint manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Viscosupplementation for Joint manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Viscosupplementation for Joint in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global Injectable Viscosupplementation for Joint market was valued at US$ 1822 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation for Joint, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation for Joint.
Report Scope
The Injectable Viscosupplementation for Joint market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Viscosupplementation for Joint market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Viscosupplementation for Joint manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Viscosupplementation for Joint manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Viscosupplementation for Joint in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable Viscosupplementation for Joint Market Overview
1.1 Product Overview and Scope of Injectable Viscosupplementation for Joint
1.2 Injectable Viscosupplementation for Joint Segment by Type
1.2.1 Global Injectable Viscosupplementation for Joint Market Value Comparison by Type (2024-2030)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Injectable Viscosupplementation for Joint Segment by Application
1.3.1 Global Injectable Viscosupplementation for Joint Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Injectable Viscosupplementation for Joint Market Size Estimates and Forecasts
1.4.1 Global Injectable Viscosupplementation for Joint Revenue 2019-2030
1.4.2 Global Injectable Viscosupplementation for Joint Sales 2019-2030
1.4.3 Global Injectable Viscosupplementation for Joint Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Viscosupplementation for Joint Market Competition by Manufacturers
2.1 Global Injectable Viscosupplementation for Joint Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Viscosupplementation for Joint Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Viscosupplementation for Joint Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Viscosupplementation for Joint Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Viscosupplementation for Joint, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Viscosupplementation for Joint, Product Type & Application
2.7 Injectable Viscosupplementation for Joint Market Competitive Situation and Trends
2.7.1 Injectable Viscosupplementation for Joint Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Viscosupplementation for Joint Players Market Share by Revenue
2.7.3 Global Injectable Viscosupplementation for Joint Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Viscosupplementation for Joint Retrospective Market Scenario by Region
3.1 Global Injectable Viscosupplementation for Joint Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Viscosupplementation for Joint Global Injectable Viscosupplementation for Joint Sales by Region: 2019-2030
3.2.1 Global Injectable Viscosupplementation for Joint Sales by Region: 2019-2024
3.2.2 Global Injectable Viscosupplementation for Joint Sales by Region: 2025-2030
3.3 Global Injectable Viscosupplementation for Joint Global Injectable Viscosupplementation for Joint Revenue by Region: 2019-2030
3.3.1 Global Injectable Viscosupplementation for Joint Revenue by Region: 2019-2024
3.3.2 Global Injectable Viscosupplementation for Joint Revenue by Region: 2025-2030
3.4 North America Injectable Viscosupplementation for Joint Market Facts & Figures by Country
3.4.1 North America Injectable Viscosupplementation for Joint Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Viscosupplementation for Joint Sales by Country (2019-2030)
3.4.3 North America Injectable Viscosupplementation for Joint Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Viscosupplementation for Joint Market Facts & Figures by Country
3.5.1 Europe Injectable Viscosupplementation for Joint Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Viscosupplementation for Joint Sales by Country (2019-2030)
3.5.3 Europe Injectable Viscosupplementation for Joint Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Viscosupplementation for Joint Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Viscosupplementation for Joint Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Viscosupplementation for Joint Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Viscosupplementation for Joint Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Injectable Viscosupplementation for Joint Market Facts & Figures by Country
3.7.1 Latin America Injectable Viscosupplementation for Joint Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Viscosupplementation for Joint Sales by Country (2019-2030)
3.7.3 Latin America Injectable Viscosupplementation for Joint Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Viscosupplementation for Joint Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Viscosupplementation for Joint Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Viscosupplementation for Joint Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Viscosupplementation for Joint Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Viscosupplementation for Joint Sales by Type (2019-2030)
4.1.1 Global Injectable Viscosupplementation for Joint Sales by Type (2019-2024)
4.1.2 Global Injectable Viscosupplementation for Joint Sales by Type (2025-2030)
4.1.3 Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2019-2030)
4.2 Global Injectable Viscosupplementation for Joint Revenue by Type (2019-2030)
4.2.1 Global Injectable Viscosupplementation for Joint Revenue by Type (2019-2024)
4.2.2 Global Injectable Viscosupplementation for Joint Revenue by Type (2025-2030)
4.2.3 Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Viscosupplementation for Joint Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Viscosupplementation for Joint Sales by Application (2019-2030)
5.1.1 Global Injectable Viscosupplementation for Joint Sales by Application (2019-2024)
5.1.2 Global Injectable Viscosupplementation for Joint Sales by Application (2025-2030)
5.1.3 Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2019-2030)
5.2 Global Injectable Viscosupplementation for Joint Revenue by Application (2019-2030)
5.2.1 Global Injectable Viscosupplementation for Joint Revenue by Application (2019-2024)
5.2.2 Global Injectable Viscosupplementation for Joint Revenue by Application (2025-2030)
5.2.3 Global Injectable Viscosupplementation for Joint Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Viscosupplementation for Joint Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Injectable Viscosupplementation for Joint Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seikagaku Injectable Viscosupplementation for Joint Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioventus Injectable Viscosupplementation for Joint Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring Injectable Viscosupplementation for Joint Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Chem Injectable Viscosupplementation for Joint Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Freda Injectable Viscosupplementation for Joint Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haohai Biological Injectable Viscosupplementation for Joint Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Viscosupplementation for Joint Industry Chain Analysis
7.2 Injectable Viscosupplementation for Joint Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Viscosupplementation for Joint Production Mode & Process
7.4 Injectable Viscosupplementation for Joint Sales and Marketing
7.4.1 Injectable Viscosupplementation for Joint Sales Channels
7.4.2 Injectable Viscosupplementation for Joint Distributors
7.5 Injectable Viscosupplementation for Joint Customers
8 Injectable Viscosupplementation for Joint Market Dynamics
8.1 Injectable Viscosupplementation for Joint Industry Trends
8.2 Injectable Viscosupplementation for Joint Market Drivers
8.3 Injectable Viscosupplementation for Joint Market Challenges
8.4 Injectable Viscosupplementation for Joint Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Injectable Viscosupplementation for Joint Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Injectable Viscosupplementation for Joint Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Injectable Viscosupplementation for Joint Market Competitive Situation by Manufacturers in 2023
Table 4. Global Injectable Viscosupplementation for Joint Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Injectable Viscosupplementation for Joint Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Injectable Viscosupplementation for Joint Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Injectable Viscosupplementation for Joint Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Injectable Viscosupplementation for Joint Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Injectable Viscosupplementation for Joint, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Injectable Viscosupplementation for Joint, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injectable Viscosupplementation for Joint, Product Type & Application
Table 12. Global Key Manufacturers of Injectable Viscosupplementation for Joint, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Viscosupplementation for Joint by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Viscosupplementation for Joint as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Viscosupplementation for Joint Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Injectable Viscosupplementation for Joint Sales by Region (2019-2024) & (K Units)
Table 18. Global Injectable Viscosupplementation for Joint Sales Market Share by Region (2019-2024)
Table 19. Global Injectable Viscosupplementation for Joint Sales by Region (2025-2030) & (K Units)
Table 20. Global Injectable Viscosupplementation for Joint Sales Market Share by Region (2025-2030)
Table 21. Global Injectable Viscosupplementation for Joint Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Injectable Viscosupplementation for Joint Revenue Market Share by Region (2019-2024)
Table 23. Global Injectable Viscosupplementation for Joint Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Injectable Viscosupplementation for Joint Revenue Market Share by Region (2025-2030)
Table 25. North America Injectable Viscosupplementation for Joint Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Injectable Viscosupplementation for Joint Sales by Country (2019-2024) & (K Units)
Table 27. North America Injectable Viscosupplementation for Joint Sales by Country (2025-2030) & (K Units)
Table 28. North America Injectable Viscosupplementation for Joint Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Injectable Viscosupplementation for Joint Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Injectable Viscosupplementation for Joint Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Injectable Viscosupplementation for Joint Sales by Country (2019-2024) & (K Units)
Table 32. Europe Injectable Viscosupplementation for Joint Sales by Country (2025-2030) & (K Units)
Table 33. Europe Injectable Viscosupplementation for Joint Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Injectable Viscosupplementation for Joint Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Injectable Viscosupplementation for Joint Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Injectable Viscosupplementation for Joint Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Injectable Viscosupplementation for Joint Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Injectable Viscosupplementation for Joint Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Injectable Viscosupplementation for Joint Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injectable Viscosupplementation for Joint Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Injectable Viscosupplementation for Joint Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Injectable Viscosupplementation for Joint Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Injectable Viscosupplementation for Joint Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable Viscosupplementation for Joint Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Injectable Viscosupplementation for Joint Sales (K Units) by Type (2019-2024)
Table 51. Global Injectable Viscosupplementation for Joint Sales (K Units) by Type (2025-2030)
Table 52. Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2019-2024)
Table 53. Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2025-2030)
Table 54. Global Injectable Viscosupplementation for Joint Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Injectable Viscosupplementation for Joint Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2019-2024)
Table 57. Global Injectable Viscosupplementation for Joint Revenue Market Share by Type (2025-2030)
Table 58. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Type (2019-2024)
Table 59. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Type (2025-2030)
Table 60. Global Injectable Viscosupplementation for Joint Sales (K Units) by Application (2019-2024)
Table 61. Global Injectable Viscosupplementation for Joint Sales (K Units) by Application (2025-2030)
Table 62. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2019-2024)
Table 63. Global Injectable Viscosupplementation for Joint Sales Market Share by Application (2025-2030)
Table 64. Global Injectable Viscosupplementation for Joint Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Injectable Viscosupplementation for Joint Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application (2019-2024)
Table 67. Global Injectable Viscosupplementation for Joint Revenue Market Share by Application (2025-2030)
Table 68. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Application (2019-2024)
Table 69. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Injectable Viscosupplementation for Joint Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Anika Therapeutics Corporation Information
Table 76. Anika Therapeutics Description and Business Overview
Table 77. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Anika Therapeutics Injectable Viscosupplementation for Joint Product
Table 79. Anika Therapeutics Recent Developments/Updates
Table 80. Seikagaku Corporation Information
Table 81. Seikagaku Description and Business Overview
Table 82. Seikagaku Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Seikagaku Injectable Viscosupplementation for Joint Product
Table 84. Seikagaku Recent Developments/Updates
Table 85. Zimmer Biomet Corporation Information
Table 86. Zimmer Biomet Description and Business Overview
Table 87. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Zimmer Biomet Injectable Viscosupplementation for Joint Product
Table 89. Zimmer Biomet Recent Developments/Updates
Table 90. Bioventus Corporation Information
Table 91. Bioventus Description and Business Overview
Table 92. Bioventus Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bioventus Injectable Viscosupplementation for Joint Product
Table 94. Bioventus Recent Developments/Updates
Table 95. Ferring Corporation Information
Table 96. Ferring Description and Business Overview
Table 97. Ferring Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ferring Injectable Viscosupplementation for Joint Product
Table 99. Ferring Recent Developments/Updates
Table 100. LG Chem Corporation Information
Table 101. LG Chem Description and Business Overview
Table 102. LG Chem Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. LG Chem Injectable Viscosupplementation for Joint Product
Table 104. LG Chem Recent Developments/Updates
Table 105. Freda Corporation Information
Table 106. Freda Description and Business Overview
Table 107. Freda Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Freda Injectable Viscosupplementation for Joint Product
Table 109. Freda Recent Developments/Updates
Table 110. Haohai Biological Corporation Information
Table 111. Haohai Biological Description and Business Overview
Table 112. Haohai Biological Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Haohai Biological Injectable Viscosupplementation for Joint Product
Table 114. Haohai Biological Recent Developments/Updates
Table 115. Shanghai Jingfeng Corporation Information
Table 116. Shanghai Jingfeng Description and Business Overview
Table 117. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product
Table 119. Shanghai Jingfeng Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Injectable Viscosupplementation for Joint Distributors List
Table 123. Injectable Viscosupplementation for Joint Customers List
Table 124. Injectable Viscosupplementation for Joint Market Trends
Table 125. Injectable Viscosupplementation for Joint Market Drivers
Table 126. Injectable Viscosupplementation for Joint Market Challenges
Table 127. Injectable Viscosupplementation for Joint Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable Viscosupplementation for Joint
Figure 2. Global Injectable Viscosupplementation for Joint Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Injectable Viscosupplementation for Joint Market Share by Type in 2023 & 2030
Figure 4. Single Injection Product Picture
Figure 5. Three Injection Product Picture
Figure 6. Five Injection Product Picture
Figure 7. Global Injectable Viscosupplementation for Joint Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Injectable Viscosupplementation for Joint Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Injectable Viscosupplementation for Joint Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Injectable Viscosupplementation for Joint Market Size (2019-2030) & (US$ Million)
Figure 14. Global Injectable Viscosupplementation for Joint Sales (2019-2030) & (K Units)
Figure 15. Global Injectable Viscosupplementation for Joint Average Price (US$/Unit) & (2019-2030)
Figure 16. Injectable Viscosupplementation for Joint Report Years Considered
Figure 17. Injectable Viscosupplementation for Joint Sales Share by Manufacturers in 2023
Figure 18. Global Injectable Viscosupplementation for Joint Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Injectable Viscosupplementation for Joint Players: Market Share by Revenue in 2023
Figure 20. Injectable Viscosupplementation for Joint Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Injectable Viscosupplementation for Joint Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Injectable Viscosupplementation for Joint Sales Market Share by Country (2019-2030)
Figure 23. North America Injectable Viscosupplementation for Joint Revenue Market Share by Country (2019-2030)
Figure 24. United States Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Injectable Viscosupplementation for Joint Sales Market Share by Country (2019-2030)
Figure 27. Europe Injectable Viscosupplementation for Joint Revenue Market Share by Country (2019-2030)
Figure 28. Germany Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Injectable Viscosupplementation for Joint Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Injectable Viscosupplementation for Joint Revenue Market Share by Region (2019-2030)
Figure 35. China Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Injectable Viscosupplementation for Joint Sales Market Share by Country (2019-2030)
Figure 45. Latin America Injectable Viscosupplementation for Joint Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Injectable Viscosupplementation for Joint Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Injectable Viscosupplementation for Joint by Type (2019-2030)
Figure 55. Global Revenue Market Share of Injectable Viscosupplementation for Joint by Type (2019-2030)
Figure 56. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Injectable Viscosupplementation for Joint by Application (2019-2030)
Figure 58. Global Revenue Market Share of Injectable Viscosupplementation for Joint by Application (2019-2030)
Figure 59. Global Injectable Viscosupplementation for Joint Price (US$/Unit) by Application (2019-2030)
Figure 60. Injectable Viscosupplementation for Joint Value Chain
Figure 61. Injectable Viscosupplementation for Joint Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
